資訊|論壇|病例

搜索

首頁 醫(yī)學(xué)論壇 專業(yè)文章 醫(yī)學(xué)進(jìn)展 簽約作者 病例中心 快問診所 愛醫(yī)培訓(xùn) 醫(yī)學(xué)考試 在線題庫 醫(yī)學(xué)會議

您所在的位置:首頁 > 腫瘤科診療指南 > 2011NICE肺癌診治指南

2011NICE肺癌診治指南

2014-05-04 16:57 閱讀:1456 來源:愛愛醫(yī) 責(zé)任編輯:張子玲
[導(dǎo)讀] This guidance updates and replaces NICE clinical guideline 24 (publishedFebruary 2005)。

    《2011NICE肺癌診治指南》內(nèi)容簡介:

    Since publication of NICE clinical guideline 24 in 2005, a number of newsystemic therapies have been granted a marketing authorisation by theEuropean Medicines Agency for use in people with NSCLC. NICE haspublished technology appraisals for pemetrexed, gefitinib and erlotinib. Othertechnology appraisals are in development.

    《2011NICE肺癌診治指南》內(nèi)容預(yù)覽:

    This guidance updates and replaces NICE clinical guideline 24 (publishedFebruary 2005)。

    New and updated recommendations are included on communication,diagnosis and staging, selection of patients with non-small-cell lung cancer(NSCLC) for treatment with curative intent, surgery with curative intent forNSCLC, smoking cessation, combination treatment for NSCLC, treatment forsmall-cell lung cancer (SCLC), managing endobronchial obstruction,managing brain metastases, and follow-up and patient perspectives.

    點(diǎn)擊下載***:《2011NICE肺癌診治指南》


分享到:
  版權(quán)聲明:

  本站所注明來源為"愛愛醫(yī)"的文章,版權(quán)歸作者與本站共同所有,非經(jīng)授權(quán)不得轉(zhuǎn)載。

  本站所有轉(zhuǎn)載文章系出于傳遞更多信息之目的,且明確注明來源和作者,不希望被轉(zhuǎn)載的媒體或個(gè)人可與我們

  聯(lián)系zlzs@120.net,我們將立即進(jìn)行刪除處理

意見反饋 關(guān)于我們 隱私保護(hù) 版權(quán)聲明 友情鏈接 聯(lián)系我們

Copyright 2002-2024 Iiyi.Com All Rights Reserved